Skip to main content
. Author manuscript; available in PMC: 2021 May 15.
Published in final edited form as: Int J Cancer. 2019 Sep 5;146(10):2756–2772. doi: 10.1002/ijc.32635

Table 3.

Relative risks (RR) and 95% confidence intervals (CI) for the association between cumulative average energy-adjusted dietary fat and cholesterol intake and ovarian cancer risk by cohort and menopausal status (NHS/NHSII)

Quartile 1 Quartile 2 Quartile 3 Quartile 4 p-trend p-het*
Total fat
Range (g/day) <53 53-<59 59-<66 ≥66
Premenopausal
NHS
Cases/PY 13/60,805 27/82,098 18/88,407 24/80,465
RR (95%CI) 1 (Ref) 1.53(0.78,2.99) 0.97(0.47,2.00) 1.41(0.69,2.87) 0.6 0.24
RR (95%CI) + fiber 1 (Ref) 1.68(0.84,3.35) 1.11(0.52,2.38) 1.76(0.81,3.80) 0.30 0.28
NHS2
Cases/PY 31/223,766 34/255,139 38/307,647 43/415,310
RR (95%CI) 1 (Ref) 0.95(0.58,1.56) 0.88(0.54,1.44) 0.72(0.44,1.18) 0.17
RR (95%CI) + fiber 1 (Ref) 0.97(0.59,1.60) 0.91(0.54,1.52) 0.75(0.44,1.30) 0.27
Postmenopausal
NHS
Cases/PY 219/406,986 176/338,912 145/259,337 78/153,217
RR (95%CI) 1 (Ref) 1.02(0.83,1.25) 1.15(0.92,1.44) 1.11(0.84,1.47) 0.27 0.11
RR (95%CI) + fiber 1 (Ref) 1.05(0.85,1.30) 1.22(0.96,1.54) 1.19(0.88,1.61) 0.13 0.12
NHS2
Cases/PY 7/36,389 16/48,214 15/61,242 12/81,006
RR (95%CI) 1 (Ref) 1.44(0.58,3.57) 1.00(0.39,2.55) 0.57(0.21,1.55) 0.09
RR (95%CI) + fiber 1 (Ref) 1.67(0.66,4.20) 1.30(0.49,3.48) 0.81(0.28,2.39) 0.40
Animal fat
Range (g/day) <27 27-<32 32-<37 ≥37
Premenopausal
NHS
Cases/PY 13/51,780 19/75,405 22/90,331 28/94,258
RR (95%CI) 1 (Ref) 0.94(0.45,1.94) 1.04(0.51,2.11) 1.21(0.60,2.45) 0.48 0.25
RR (95%CI) + fiber 1 (Ref) 1.06(0.50,2.22) 1.25(0.59,2.64) 1.56(0.72,3.42) 0.20 0.29
NHS2
Cases/PY 36/229,030 29/261,550 40/316,030 41/395,253
RR (95%CI) 1 (Ref) 0.72(0.44,1.19) 0.86(0.54,1.36) 0.71(0.44,1.15) 0.26
RR (95%CI) + fiber 1 (Ref) 0.74(0.44,1.24) 0.89(0.54,1.46) 0.75(0.44,1.30) 0.44
Postmenopausal
NHS
Cases/PY 201/382,689 174/327,001 138/261,279 105/187,484
RR (95%CI) 1 (Ref) 1.10(0.89,1.35) 1.16(0.92,1.46) 1.38(1.07,1.79) 0.02 0.12
RR (95%CI) + fiber 1 (Ref) 1.16(0.94,1.45) 1.27(0.99,1.62) 1.57(1.17,2.09) <0.01 0.14
NHS2
Cases/PY 17/57,559 12/58,194 12/57,219 9/53,878
RR (95%CI) 1 (Ref) 0.55(0.26,1.20) 0.63(0.29,1.37) 0.51(0.21,1.21) 0.15
RR (95%CI) + fiber 1 (Ref) 0.68(0.30,1.54) 0.84(0.36,1.97) 0.76(0.28,2.05) 0.68
Vegetable fat
Range (g/day) <22 22-<27 27-<31 ≥31
Premenopausal
NHS
Cases/PY 26/93,485 23/79,476 13/74,614 20/64,199
RR (95%CI) 1 (Ref) 1.08(0.61,1.94) 0.66(0.33,1.31) 1.24(0.66,2.33) 0.81 0.89
RR (95%CI) + fiber 1 (Ref) 1.11(0.62,1.99) 0.7(0.35,1.40) 1.36(0.72,2.61) 0.58 0.91
NHS2
Cases/PY 22/263,597 41/286,486 42/308,069 41/343,711
RR (95%CI) 1 (Ref) 1.67(0.99,2.82) 1.51(0.89,2.57) 1.25(0.72,2.17) 0.82
RR (95%CI) + fiber 1 (Ref) 1.67(0.99,2.83) 1.51(0.89,2.58) 1.25(0.72,2.18) 0.81
Postmenopausal
NHS
Cases/PY 175/349,834 179/318,780 147/277,945 117/211,893
RR (95%CI) 1 (Ref) 1.09(0.88,1.35) 1.01(0.80,1.27) 1.09(0.85,1.41) 0.61 0.14
RR (95%CI) + fiber 1 (Ref) 1.11(0.89,1.37) 1.04(0.83,1.32) 1.15(0.89,1.49) 0.38 0.12
NHS2
Cases/PY 7/26,087 6/43,274 20/62,163 17/95,327
RR (95%CI) 1 (Ref) 0.41(0.13,1.23) 0.84(0.34,2.07) 0.38(0.15,0.98) 0.09
RR (95%CI) + fiber 1 (Ref) 0.44(0.14,1.35) 0.94(0.38,2.34) 0.45(0.17,1.17) 0.17
Saturated fat
Range (g/day) <18 18-<20 20-<23 ≥23
Premenopausal
NHS
Cases/PY 9/49,879 21/75,745 27/92,705 25/93,445
RR (95%CI) 1 (Ref) 1.71(0.73,3.98) 2.21(0.89,5.49) 2.14(0.73,6.31) 0.22 0.38
RR (95%CI) + fiber 1 (Ref) 1.84(0.78,4.34) 2.45(0.97,6.18) 2.43(0.82,7.23) 0.16 0.41
NHS2
Cases/PY 40/220,588 17/259,343 43/317,581 46/404,351
RR (95%CI) 1 (Ref) 0.38(0.21,0.70) 0.90(0.53,1.53) 0.81(0.42,1.55) 0.91
RR (95%CI) + fiber 1 (Ref) 0.39(0.21,0.71) 0.91(0.53,1.57) 0.83(0.42,1.61) 0.85
Postmenopausal
NHS
Cases/PY 221/405,019 177/332,568 137/254,004 83/166,861
RR (95%CI) 1 (Ref) 1.10(0.88,1.38) 1.21(0.92,1.58) 1.24(0.88,1.76) 0.17 0.17
RR (95%CI) + fiber 1 (Ref) 1.13(0.90,1.42) 1.25(0.95,1.64) 1.30(0.91,1.85) 0.11 0.19
NHS2
Cases/PY 12/49,524 17/55,558 10/59,531 11/62,239
RR (95%CI) 1 (Ref) 1.13(0.49,2.63) 0.67(0.24,1.85) 0.70(0.22,2.30) 0.39
RR (95%CI) + fiber 1 (Ref) 1.37(0.58,3.21) 0.82(0.30,2.29) 0.97(0.29,3.18) 0.71
Monounsaturated fat
Range (g/day) <19.7 19.7-<22.5 22.5-<25.4 ≥25.4
Premenopausal
NHS
Cases/PY 19/73,443 18/88,611 27/88,122 18/61,597
RR (95%CI) 1 (Ref) 0.73(0.35,1.53) 1.23(0.54,2.81) 1.09(0.36,3.28) 0.67 0.14
RR (95%CI) + fiber 1 (Ref) 0.76(0.36,1.59) 1.29(0.57,2.95) 1.14(0.38,3.38) 0.62 0.15
NHS2
Cases/PY 26/216,921 39/247,670 39/311,742 42/425,530
RR (95%CI) 1 (Ref) 1.29(0.75,2.23) 1.05(0.56,1.95) 0.77(0.35,1.68) 0.32
RR (95%CI) + fiber 1 (Ref) 1.29(0.75,2.23) 1.05(0.56,1.96) 0.78(0.36,1.69) 0.32
Postmenopausal
NHS
Cases/PY 220/403,683 170/343,316 152/262,826 76/148,627
RR (95%CI) 1 (Ref) 0.92(0.73,1.16) 1.10(0.82,1.46) 0.97(0.66,1.42) 0.88 0.06
RR (95%CI) + fiber 1 (Ref) 0.92(0.73,1.17) 1.10(0.83,1.47) 0.97(0.66,1.43) 0.86 0.07
NHS2
Cases/PY 9/33,130 13/45,113 14/60,660 14/87,948
RR (95%CI) 1 (Ref) 0.91(0.36,2.30) 0.63(0.22,1.78) 0.42(0.12,1.52) 0.14
RR (95%CI) + fiber 1 (Ref) 1.12(0.43,2.91) 0.81(0.28,2.36) 0.58(0.16,2.10) 0.29
Polyunsaturated fat
Range (g/day) <9.4 9.4-<10.7 10.7-<12.3 ≥12.3
Premenopausal
NHS
Cases/PY 17/69,607 16/68,916 19/75,794 30/97,457
RR (95%CI) 1 (Ref) 0.92(0.45,1.91) 1.14(0.56,2.33) 1.42(0.68,2.98) 0.25 0.23
RR (95%CI) + fiber 1 (Ref) 0.89(0.43,1.84) 1.08(0.53,2.21) 1.31(0.62,2.76) 0.36 0.23
NHS2
Cases/PY 31/296,975 42/304,560 43/298,161 30/302,167
RR (95%CI) 1 (Ref) 1.30(0.80,2.11) 1.34(0.80,2.23) 0.91(0.50,1.66) 0.63
RR (95%CI) + fiber 1 (Ref) 1.29(0.79,2.11) 1.33(0.79,2.23) 0.90(0.49,1.66) 0.61
Postmenopausal
NHS
Cases/PY 157/331,358 178/301,563 147/279,239 136/246,291
RR (95%CI) 1 (Ref) 1.25(0.99,1.56) 1.12(0.87,1.44) 1.25(0.94,1.66) 0.23 0.04
RR (95%CI) + fiber 1 (Ref) 1.24(0.98,1.55) 1.11(0.86,1.43) 1.23(0.92,1.63) 0.29 0.04
NHS2
Cases/PY 7/34,041 11/51,398 23/65,796 9/75,617
RR (95%CI) 1 (Ref) 1.06(0.40,2.86) 1.56(0.60,4.03) 0.55(0.17,1.74) 0.23
RR (95%CI) + fiber 1 (Ref) 0.98(0.37,2.64) 1.31(0.50,3.42) 0.39(0.12,1.27) 0.07
Trans fat
Range (g/day) <2.1 2.1-<2.6 2.6-<3.3 ≥3.3
Premenopausal
NHS
Cases/PY 12/46,221 18/65,131 25/87,844 27/112,578
RR (95%CI) 1 (Ref) 1.05(0.49,2.25) 1.04(0.48,2.22) 0.79(0.34,1.82) 0.44 0.49
RR (95%CI) + fiber 1 (Ref) 1.12(0.52,2.42) 1.14(0.52,2.47) 0.89(0.38,2.09) 0.62 0.51
NHS2
Cases/PY 43/241,641 33/270,738 33/305,277 37/384,207
RR (95%CI) 1 (Ref) 0.74(0.46,1.19) 0.64(0.38,1.07) 0.64(0.36,1.13) 0.14
RR (95%CI) + fiber 1 (Ref) 0.74(0.45,1.20) 0.64(0.38,1.08) 0.63(0.35,1.14) 0.15
Postmenopausal
NHS
Cases/PY 209/359,941 186/319,710 136/279,756 87/199,043
RR (95%CI) 1 (Ref) 0.97(0.78,1.20) 0.84(0.66,1.08) 0.80(0.58,1.08) 0.09 0.36
RR (95%CI) + fiber 1 (Ref) 0.99(0.80,1.23) 0.86(0.67,1.11) 0.83(0.60,1.13) 0.17 0.34
NHS2
Cases/PY 14/68,940 19/62,463 6/56,643 11/38,805
RR (95%CI) 1 (Ref) 1.69(0.78,3.68) 0.69(0.23,2.07) 2.07(0.73,5.86) 0.35
RR (95%CI) + fiber 1 (Ref) 2.15(0.96,4.79) 1(0.32,3.09) 3.24(1.08,9.73) 0.09
Cholesterol
Range (g/day) <196 196-<230 230-<270 ≥270
Premenopausal
NHS
Cases/PY 18/47,014 18/61,449 11/78,904 35/124,407
RR (95%CI) 1 (Ref) 0.73(0.37,1.43) 0.37(0.17,0.80) 0.73(0.40,1.33) 0.43 0.64
RR (95%CI) + fiber 1 (Ref) 0.75(0.38,1.50) 0.39(0.18,0.85) 0.78(0.42,1.45) 0.58 0.59
NHS2
Cases/PY 40/297,569 34/307,521 37/306,972 35/289,801
RR (95%CI) 1 (Ref) 0.83(0.52,1.32) 0.85(0.54,1.34) 0.82(0.51,1.32) 0.46
RR (95%CI) + fiber 1 (Ref) 0.85(0.53,1.36) 0.88(0.55,1.40) 0.86(0.53,1.41) 0.61
Postmenopausal
NHS
Cases/PY 174/318,224 151/293,880 130/280,891 163/265,457
RR (95%CI) 1 (Ref) 0.98(0.78,1.22) 0.93(0.74,1.18) 1.36(1.08,1.71) 0.02 0.72
RR (95%CI) + fiber 1 (Ref) 1.00(0.80,1.25) 0.96(0.76,1.22) 1.41(1.11,1.79) 0.01 0.76
NHS2
Cases/PY 14/59,368 12/60,808 13/58,161 11/48,515
RR (95%CI) 1 (Ref) 0.84(0.38,1.83) 0.98(0.45,2.15) 1.04(0.46,2.39) 0.85
RR (95%CI) + fiber 1 (Ref) 1.00(0.45,2.25) 1.24(0.55,2.82) 1.43(0.59,3.45) 0.37
*

p-het=p-for-heterogeneity by cohort (NHS, NHSII)

PY=person-years

Models adjusted for age (continuous), calendar year (continuous), total caloric intake (continuous), family history of ovarian cancer (no, yes), age at menarche (continuous), tubal ligation (no, yes), hysterectomy (no, yes, unknown), unilateral oophorectomy (no, yes, unknown), BMI (kg/m2, continuous), nulliparity (no, yes), parity (continuous), oral contraceptive use (never, <1, 1–5, 5+yrs), smoking (pack-years, continuous), menopausal status (premenopausal, postmenopausal), estrogen only HT use (never, past <5 years, past 5+ years, current <5 years, current 5+ years), estrogen + progestin HT use (never, past <5 years, past 5+ years, current <5 years, current 5+ years), other HT use (never, past <5 years, past 5+ years, current <5 years, current 5+ years), lactose intake (g/day, continuous), caffeine intake (mg/day, continuous), fiber intake (g/day, continuous), and physical activity (METs/week: 0–3.8, >3.8–11.1, >11.1–26.4, >26.4, unknown). Vegetable fat and animal fat were mutually adjusted for each other. Saturated fat, polyunsaturated fat, monounsaturated fat, and trans-unsaturated fat were mutually adjusted for each other.